跳至主要内容
临床试验/ITMCTR1900002883
ITMCTR1900002883尚未招募未知

A randomized clinical trial for Erxian Decoction and Guizhi Decoction in the treatment of Perimenopausal Syndrome (PMS)

The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
Female

入选标准

  • 1. Women over 40 years old;
  • 2. According to the diagnosis of perimenopausal syndrome, there were more than two changes in the length of the adjacent menstrual cycle > 7 days in 10 months, and FSH > 10u/L (those with menstruation were still detected within the second to third days of menstrual cycle);
  • 3. The score of modified Kupperman index was more than 15;
  • 4. Signed informed consent.

排除标准

  • 1. Uterine fibroids > 3cm, or adenomyosis, or endometriosis, or bilateral ovariectomy, or severe hyperplasia of the breast, or malignant tumors of the reproductive system;
  • 2. The vagina irregular bleeding with unknown cause was not cured;
  • 3. Patients with severe primary diseases or psychosis, such as cardiovascular, cerebrovascular, liver, kidney, endocrine and hematopoietic system;
  • 4. Those who have used sex hormone drugs in the past 3 months;
  • 5. Presence of conditions affecting oral drug absorption (such as gastrectomy);
  • 6. Patients with allergic constitution;
  • 7. Those who have used antibiotics in the past 2 weeks.

研究者

发起方
The First Affiliated Hospital of Guangzhou University of Chinese Medicine

相似试验